In particular, the AFB1-serum albumin adduct [24,25] is useful not only for estimation of liver cancer risk [26], but also–thanks to the long half-life of albumin in circulation [27]–for monitoring past exposures on a timescale of months. The gene discussed is ALB; the disease is liver cancer.